CROSS COUNTRY HEALTHCARE INC (CCRN) Fundamental Analysis & Valuation

NASDAQ:CCRN • US2274831047

Current stock price

9.52 USD
-0.21 (-2.16%)
At close:
9.52 USD
0 (0%)
After Hours:

This CCRN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CCRN Profitability Analysis

1.1 Basic Checks

  • In the past year CCRN was profitable.
  • CCRN had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: CCRN reported negative net income in multiple years.
  • CCRN had a positive operating cash flow in 4 of the past 5 years.
CCRN Yearly Net Income VS EBIT VS OCF VS FCFCCRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

1.2 Ratios

  • CCRN has a worse Return On Assets (-21.13%) than 81.00% of its industry peers.
  • With a Return On Equity value of -29.38%, CCRN is not doing good in the industry: 67.00% of the companies in the same industry are doing better.
  • With a Return On Invested Capital value of 0.54%, CCRN is not doing good in the industry: 63.00% of the companies in the same industry are doing better.
  • The Average Return On Invested Capital over the past 3 years for CCRN is below the industry average of 8.85%.
  • The 3 year average ROIC (6.06%) for CCRN is well above the current ROIC(0.54%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -21.13%
ROE -29.38%
ROIC 0.54%
ROA(3y)-4.3%
ROA(5y)5%
ROE(3y)-5.84%
ROE(5y)13.62%
ROIC(3y)6.06%
ROIC(5y)14.51%
CCRN Yearly ROA, ROE, ROICCCRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • The Operating Margin of CCRN (0.24%) is worse than 63.00% of its industry peers.
  • In the last couple of years the Operating Margin of CCRN has declined.
  • CCRN has a Gross Margin (20.26%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of CCRN has declined.
Industry RankSector Rank
OM 0.24%
PM (TTM) N/A
GM 20.26%
OM growth 3Y-71.15%
OM growth 5Y-31.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y-3.52%
CCRN Yearly Profit, Operating, Gross MarginsCCRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. CCRN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CCRN is destroying value.
  • Compared to 1 year ago, CCRN has less shares outstanding
  • CCRN has less shares outstanding than it did 5 years ago.
  • CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CCRN Yearly Shares OutstandingCCRN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
CCRN Yearly Total Debt VS Total AssetsCCRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • CCRN has an Altman-Z score of 4.82. This indicates that CCRN is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.82, CCRN belongs to the best of the industry, outperforming 83.00% of the companies in the same industry.
  • CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.82
ROIC/WACC0.06
WACC9.08%
CCRN Yearly LT Debt VS Equity VS FCFCCRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 3.78 indicates that CCRN has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.78, CCRN belongs to the top of the industry, outperforming 88.00% of the companies in the same industry.
  • A Quick Ratio of 3.78 indicates that CCRN has no problem at all paying its short term obligations.
  • The Quick ratio of CCRN (3.78) is better than 89.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.78
Quick Ratio 3.78
CCRN Yearly Current Assets VS Current LiabilitesCCRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CCRN Growth Analysis

3.1 Past

  • The earnings per share for CCRN have decreased strongly by -95.56% in the last year.
  • CCRN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -46.59% yearly.
  • The Revenue for CCRN has decreased by -21.56% in the past year. This is quite bad
  • CCRN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.74% yearly.
EPS 1Y (TTM)-95.56%
EPS 3Y-84.39%
EPS 5Y-46.59%
EPS Q2Q%-250%
Revenue 1Y (TTM)-21.56%
Revenue growth 3Y-27.85%
Revenue growth 5Y4.74%
Sales Q2Q%-23.61%

3.2 Future

  • The Earnings Per Share is expected to grow by 128.64% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, CCRN will show a decrease in Revenue. The Revenue will decrease by 0.00% on average per year.
EPS Next Y388.12%
EPS Next 2Y128.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-8.8%
Revenue Next 2Y-2.17%
Revenue Next 3Y0%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCRN Yearly Revenue VS EstimatesCCRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
CCRN Yearly EPS VS EstimatesCCRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. CCRN Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 476.00 indicates a quite expensive valuation of CCRN.
  • 60.00% of the companies in the same industry are cheaper than CCRN, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 24.88. CCRN is valued rather expensively when compared to this.
  • A Price/Forward Earnings ratio of 97.52 indicates a quite expensive valuation of CCRN.
  • Based on the Price/Forward Earnings ratio, CCRN is valued a bit more expensive than 61.00% of the companies in the same industry.
  • CCRN is valuated expensively when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 476
Fwd PE 97.52
CCRN Price Earnings VS Forward Price EarningsCCRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

  • CCRN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CCRN is cheaper than 69.00% of the companies in the same industry.
  • 86.00% of the companies in the same industry are more expensive than CCRN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.67
EV/EBITDA 10.64
CCRN Per share dataCCRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • CCRN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CCRN's earnings are expected to grow with 128.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.23
PEG (5Y)N/A
EPS Next 2Y128.64%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CCRN Dividend Analysis

5.1 Amount

  • CCRN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CCRN Fundamentals: All Metrics, Ratios and Statistics

CROSS COUNTRY HEALTHCARE INC

NASDAQ:CCRN (3/27/2026, 8:05:02 PM)

After market: 9.52 0 (0%)

9.52

-0.21 (-2.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-04
Earnings (Next)05-05
Inst Owners84.61%
Inst Owner Change-19.96%
Ins Owners6.23%
Ins Owner Change11.51%
Market Cap307.69M
Revenue(TTM)1.05B
Net Income(TTM)-94.85M
Analysts70.67
Price Target11.9 (25%)
Short Float %4.29%
Short Ratio2.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-157.94%
Min EPS beat(2)-296.08%
Max EPS beat(2)-19.79%
EPS beat(4)1
Avg EPS beat(4)-107.17%
Min EPS beat(4)-296.08%
Max EPS beat(4)5.59%
EPS beat(8)3
Avg EPS beat(8)-61.22%
EPS beat(12)6
Avg EPS beat(12)-39.22%
EPS beat(16)10
Avg EPS beat(16)-25.76%
Revenue beat(2)0
Avg Revenue beat(2)-9.09%
Min Revenue beat(2)-9.46%
Max Revenue beat(2)-8.72%
Revenue beat(4)0
Avg Revenue beat(4)-7.87%
Min Revenue beat(4)-9.46%
Max Revenue beat(4)-5.84%
Revenue beat(8)0
Avg Revenue beat(8)-4.22%
Revenue beat(12)2
Avg Revenue beat(12)-2.78%
Revenue beat(16)5
Avg Revenue beat(16)-1.59%
PT rev (1m)-0.66%
PT rev (3m)-22.47%
EPS NQ rev (1m)-376.2%
EPS NQ rev (3m)-376.2%
EPS NY rev (1m)-19.12%
EPS NY rev (3m)-24.93%
Revenue NQ rev (1m)-7.48%
Revenue NQ rev (3m)-7.48%
Revenue NY rev (1m)-3.59%
Revenue NY rev (3m)-3.13%
Valuation
Industry RankSector Rank
PE 476
Fwd PE 97.52
P/S 0.29
P/FCF 7.67
P/OCF 6.38
P/B 0.95
P/tB 1.33
EV/EBITDA 10.64
EPS(TTM)0.02
EY0.21%
EPS(NY)0.1
Fwd EY1.03%
FCF(TTM)1.24
FCFY13.03%
OCF(TTM)1.49
OCFY15.68%
SpS32.62
BVpS9.99
TBVpS7.16
PEG (NY)1.23
PEG (5Y)N/A
Graham Number2.12
Profitability
Industry RankSector Rank
ROA -21.13%
ROE -29.38%
ROCE 0.68%
ROIC 0.54%
ROICexc 0.76%
ROICexgc 1.17%
OM 0.24%
PM (TTM) N/A
GM 20.26%
FCFM 3.8%
ROA(3y)-4.3%
ROA(5y)5%
ROE(3y)-5.84%
ROE(5y)13.62%
ROIC(3y)6.06%
ROIC(5y)14.51%
ROICexc(3y)6.35%
ROICexc(5y)14.73%
ROICexgc(3y)10.08%
ROICexgc(5y)21.91%
ROCE(3y)7.68%
ROCE(5y)18.37%
ROICexgc growth 3Y-70.95%
ROICexgc growth 5Y-31.89%
ROICexc growth 3Y-71.51%
ROICexc growth 5Y-28.12%
OM growth 3Y-71.15%
OM growth 5Y-31.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y-3.52%
F-Score6
Asset Turnover2.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 48.59%
Cap/Sales 0.77%
Interest Coverage 1.82
Cash Conversion 249.59%
Profit Quality N/A
Current Ratio 3.78
Quick Ratio 3.78
Altman-Z 4.82
F-Score6
WACC9.08%
ROIC/WACC0.06
Cap/Depr(3y)57.55%
Cap/Depr(5y)63.04%
Cap/Sales(3y)0.7%
Cap/Sales(5y)0.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-95.56%
EPS 3Y-84.39%
EPS 5Y-46.59%
EPS Q2Q%-250%
EPS Next Y388.12%
EPS Next 2Y128.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.56%
Revenue growth 3Y-27.85%
Revenue growth 5Y4.74%
Sales Q2Q%-23.61%
Revenue Next Year-8.8%
Revenue Next 2Y-2.17%
Revenue Next 3Y0%
Revenue Next 5YN/A
EBIT growth 1Y103.69%
EBIT growth 3Y-79.18%
EBIT growth 5Y-28.09%
EBIT Next Year297.63%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-64.01%
FCF growth 3Y-31.6%
FCF growth 5Y12.15%
OCF growth 1Y-59.83%
OCF growth 3Y-28.87%
OCF growth 5Y12.15%

CROSS COUNTRY HEALTHCARE INC / CCRN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CCRN.


What is the valuation status for CCRN stock?

ChartMill assigns a valuation rating of 4 / 10 to CROSS COUNTRY HEALTHCARE INC (CCRN). This can be considered as Fairly Valued.


Can you provide the profitability details for CROSS COUNTRY HEALTHCARE INC?

CROSS COUNTRY HEALTHCARE INC (CCRN) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for CCRN stock?

The Earnings per Share (EPS) of CROSS COUNTRY HEALTHCARE INC (CCRN) is expected to grow by 388.12% in the next year.